Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : Agouron Pharmaceuticals (AGPH) -- Ignore unavailable to you. Want to Upgrade?

To: scaram(o)uche who wrote (5992)	1/27/1999 8:09:00 AM
From: sam	Read Replies (1) \| Respond to of 6136

Although the deal IMO was not the best "financially" for current AGPH shareholders (based on Tuesday's closing price), I believe one of the major reasons behind the deal was the ability for AGPH to remain essentially autonomous, while getting WLA's cash to continue developing their own products. AGPH now becomes WLA's AIDS division. And they will hold their own (as they already are) very well in that area. The big winner here is clearly WLA. They get AGPH, Viracept, AGPH's pipeline, its drug discovery program (including Alanex), and its winning salesforce for NO significant premium. WLA worked out a great deal (unless there's something we don't know about looming ahead for AGPH). Now they'll be working for AGPH's shareholders, too.

To: scaram(o)uche who wrote (5992)	1/27/1999 5:36:00 PM
From: Clive Roberts	Read Replies (1) \| Respond to of 6136

Richard You wrote "AGPH online" got launched in misc.invest.stocks in the Spring of '95. Clive Taylor was there. There were the biotech nuts.... John Metcalf, Rudy Saucillo, Jim Silverman, Dr. John Dwyer, Dr. Mike Solomon, Shahram Mori, Dr. John de Castro, Paul Yadlowski, Ron Bartlett, Dr. Purshotam Bhan, Dr. Jerry McLaughlin, Dr. Mark Henderson, Dr. John Loike, John Fitisoff, Dr. Kevin Jones, and many others. I do not believe that any one of them could have anything other than admiration for the job that Peter Johnson and team have done." Hey Ricardo ......Clive Roberts.....who's this Clive Taylor geezer! I tend to agree. If Peter Johnson can bring AGPH to their current position, then he's more than equipped to negotiate the price. He brought AGPH from nothing to beat the mighty Merck. Also everything that AGPH have achieved and delivered points to a company and management structure of real integrity.